Antibiotice S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was RON 376.76 million compared to RON 346.78 million a year ago. Net income was RON 29.94 million compared to RON 26.39 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 RON | -0.99% | -3.23% | +115.05% |
Jun. 06 | Antibiotice S.A. announced that it expects to receive $108.96 million in funding | CI |
May. 15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+115.05% | 442M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- ATB Stock
- News Antibiotice S.A.
- Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2021